Latest Biological Safety Testing Market Research Report 2020:
The report includes the latest coverage of the impact of COVID-19 on the Biological Safety Testing Market. The incidence has affected nearly every aspect of the business domain. This study evaluates the current scenario and predicts future outcomes of the pandemic on the global economy.
The Biological Safety Testing Market is expected to reach USD 6.99 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the increasing predominance of lifestyle-associated chronic diseases such as diabetes and cancer that serves as an essential contributing factor towards improving drug development and their following commercialization which are expected to drive the market growth.
Get a Sample Copy of the Biological Safety Testing Market Report: https://www.reportsanddata.com/sample-enquiry-form/1412
Companies considered and profiled in this market study
Charles River Laboratories International Inc., SGS SA, Lonza Group, Sigma-Aldrich Corporation, WuXiPharmaTech Inc., Avance Biosciences Inc., BSL Bioservice, Merck KGaA, Cytovance Biologics Inc., and Toxikon Corporation, among others.
Biologics are products manufactured from living organisms and has a unique set of features. Safety of biologics and specialized evaluation of the same is of the highest importance. Biological safety testing is essential for new products launching. Biological safety testing is performed to assure a safe quality and non-contamination of vaccines and biopharmaceuticals.
Accelerated growth in biotechnology and pharmaceutical industries, increasing prevalence of chronic diseases, rise in population, rise in R&D investment in life sciences, increasing number of innovative product launches, and increasing government support for biotechnology and pharmaceutical industries are some important factors for the North America region to account for the largest share of 37.3% of the market in 2018.
For the purpose of this report, Reports and Data have segmented the global Biological Safety Testing market according to Product, Component, Application, End-user, and Region:
Product Outlook (Revenue, USD Million; 2016-2026)
Reagents & kits
Instruments
Services
Application Outlook (Revenue, USD Million; 2016-2026)
Vaccines & therapeutics
Stem cell
Tissue & tissue-based products
Gene therapy
Blood & blood-based therapy
For Discount on Biological Safety Testing Market Report before purchase, visit here: https://www.reportsanddata.com/discount-enquiry-form/1412
Test Type Outlook (Revenue, USD Million; 2016-2026)
Endotoxin tests
Bioburden tests
Adventitious agent detection tests
Residual host contamination detection tests
Sterility tests
Cell line authentication and characterization tests
Others
Regional Outlook (Revenue in USD Million; 2020–2026)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Reasons to buy Biological Safety Testing Market Report:
Have specific requirements for the Biological Safety Testing market report? Consult with our Industry Expert regarding the coverage of the report: https://www.reportsanddata.com/report-detail/global-in-vitro-diagnosticsivd-market
We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.